A
Abingworth Portfolio holdings
AUM
$307M
This Quarter Return
-5.1%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$175M
AUM Growth
+$175M
(+35%)
Cap. Flow
+$19M
Cap. Flow
% of AUM
10.84%
Top 10 Holdings %
Top 10 Hldgs %
99.68%
Holding
12
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
RNA
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
|
$41M |
Top Sells
| 1 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
$12.3M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$9.69M |
Sector Composition
| 1 | Healthcare | 56.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$311M
| $51.1M | 29.12% |
8,087,486
| – | – |
|
|
RNA
2
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $41M | 23.37% |
+6,213,924
| New | +$41M |
|
|
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $33.2M | 18.92% |
1,240,917
| – | – |
|
4
Supernus Pharmaceuticals
SUPN
$2.53B
| $26.4M | 15.02% |
3,600,000
| – | – |
|
|
CEMP
5
DELISTED
Cempra, Inc.
CEMP
| $8.21M | 4.68% |
714,285
| – | – |
|
6
Achieve Life Sciences
ACHV
$152M
| $5.61M | 3.2% |
603,740
| – | – |
|
|
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
| $4.32M | 2.46% |
2,335,218
| – | – |
|
|
ANTH
8
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $1.76M | 1% |
437,995
-3,065,961
| -87% | -$12.3M |
|
|
GWPH
9
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.74M | 0.99% |
102,200
| – | – |
|
|
HPTX
10
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $1.63M | 0.93% |
62,500
| – | – |
|
|
ZLCS
11
DELISTED
ZALICUS INC COM NEW
ZLCS
| $564K | 0.32% |
473,800
| – | – |
|
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| – | – |
-313,053
| Closed | -$9.69M |
|